Solid Biosciences (SLDB) Cash & Current Investments (2017 - 2024)
Historic Cash & Current Investments for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $171.1 million.
- Solid Biosciences' Cash & Current Investments rose 1975.94% to $171.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $171.1 million, marking a year-over-year increase of 1975.94%. This contributed to the annual value of $123.6 million for FY2023, which is 4214.91% down from last year.
- As of Q3 2024, Solid Biosciences' Cash & Current Investments stood at $171.1 million, which was up 1975.94% from $190.3 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Cash & Current Investments ranged from a high of $268.5 million in Q1 2021 and a low of $24.8 million during Q3 2020
- Over the past 5 years, Solid Biosciences' median Cash & Current Investments value was $162.9 million (recorded in 2022), while the average stood at $154.7 million.
- As far as peak fluctuations go, Solid Biosciences' Cash & Current Investments plummeted by 7653.2% in 2020, and later skyrocketed by 40104.88% in 2021.
- Over the past 5 years, Solid Biosciences' Cash & Current Investments (Quarter) stood at $154.7 million in 2020, then soared by 34.27% to $207.8 million in 2021, then increased by 2.86% to $213.7 million in 2022, then tumbled by 42.15% to $123.6 million in 2023, then soared by 38.4% to $171.1 million in 2024.
- Its Cash & Current Investments was $171.1 million in Q3 2024, compared to $190.3 million in Q2 2024 and $206.1 million in Q1 2024.